These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 9561455)

  • 1. [Alternating dosage of bisoprolol?].
    Wehling M
    Internist (Berl); 1998 Mar; 39(3):316. PubMed ID: 9561455
    [No Abstract]   [Full Text] [Related]  

  • 2. A pharmacokinetic comparison of generic tablets containing bisoprolol with the innovator formulation in healthy volunteers.
    Jovanović D; Cusić S; Rancić D; Srnić D; Perković-Vukcević N
    J Clin Pharmacol; 2006 Oct; 46(10):1217-22. PubMed ID: 16988212
    [No Abstract]   [Full Text] [Related]  

  • 3. [Every 2nd heart failure patient without beta blocker. "Intolerance" is often a dosage error].
    MMW Fortschr Med; 2003 Feb; 145(6):58. PubMed ID: 12619366
    [No Abstract]   [Full Text] [Related]  

  • 4. "Bisoprolol dose-response relationship in patients with congestive heart failure: a subgroup analysis in the cardiac insufficiency bisoprolol study(CIBIS II)," by Simon T.
    Krum H; Hare D
    Eur Heart J; 2004 Feb; 25(3):277. PubMed ID: 14972430
    [No Abstract]   [Full Text] [Related]  

  • 5. [Beta blockers in heart failure. Start with low and slowly increase the dosage!].
    MMW Fortschr Med; 2002 Sep; 144(38):59. PubMed ID: 12395713
    [No Abstract]   [Full Text] [Related]  

  • 6. [New indications for beta blockers. Cave hypertension focus/heart failure].
    MMW Fortschr Med; 2000 Jan; 142(1-2):52-3. PubMed ID: 11294191
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization.
    Zhao JH; Fu JH; Wang SM; Su CH; Shan Y; Kong SJ; Wang Y; Lu WL; Zhang H; Zhang S; Li L; Zhang EH; Wang L; Pei QL; Wang JC; Zhang X; Zhang Q
    Int J Pharm; 2007 Jun; 337(1-2):88-101. PubMed ID: 17267147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activity of the autonomic nervous system in patients with congestive heart failure - is it worth evaluating?].
    Szydło K
    Kardiol Pol; 2009 Sep; 67(9):971-2. PubMed ID: 19938362
    [No Abstract]   [Full Text] [Related]  

  • 9. [Beta blocker in heart failure. A little is better than nothing].
    MMW Fortschr Med; 2003 Oct; 145(41):47. PubMed ID: 14655485
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical and hemodynamic efficacy of selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease].
    Fedorova TA; Il'ina IuV; Sotnikova TI; Rybakova MK; Loshchits NV
    Ter Arkh; 2004; 76(3):62-8. PubMed ID: 15108463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisoprolol pilot studies in myocardial infarction.
    de Muinck ED; Lie KI; von Mengden HJ; Reck R; Verkenne P
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S196-200. PubMed ID: 11527129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of the efficacy of bisoprolol administration by cardiopulmonary exercise testing in patients with heart failure].
    Terzi S; Dayi SU; Akbulut T; Dağ O; Köse H; Satiroğlu O; Sayar N; Bilsel T; Aksoy S; Yeşilçimen K
    Anadolu Kardiyol Derg; 2003 Dec; 3(4):313-8. PubMed ID: 14675880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A must in symptomatic heart failure. Added beta blocker improves prognosis].
    MMW Fortschr Med; 2001 Feb; 143(5):50-1. PubMed ID: 11234521
    [No Abstract]   [Full Text] [Related]  

  • 14. [Correlation between pharmacokinetics and dynamics: explanation of clinical aspects exemplified by beta-receptor blockers].
    Palm D; Wellstein A; Schloos J; Belz GG
    Verh Dtsch Ges Inn Med; 1991; 97():338-42. PubMed ID: 1687299
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of bisoprolol and procainamide in human cardiac impulse generation and conduction.
    Verrostte JM; van Hemel NM; Kingma JH
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S193-5. PubMed ID: 11527128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heart failure. Only every fifth patient is properly treated?].
    MMW Fortschr Med; 2002 Jun; 144(25):56. PubMed ID: 12136677
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vascular interventions. Beta blocker protects the heart].
    MMW Fortschr Med; 2001 Aug; 143(33-34):60. PubMed ID: 11561466
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adrenergic beta-Antagonists in prevention of cardiovascular complications in major non-cardiac surgery].
    Pikto-Pietkiewicz W
    Kardiol Pol; 2006 Sep; 64(9):1028-30. PubMed ID: 17201042
    [No Abstract]   [Full Text] [Related]  

  • 19. Bisoprolol: studies of potential interactions with theophylline and warfarin in healthy volunteers.
    Warrington SJ; Johnston A; Lewis Y; Murphy M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S164-8. PubMed ID: 11527121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-cardiac vascular surgery. Perioperative beta blockade protects the heart].
    MMW Fortschr Med; 2001 Jan; 143(1-2):52. PubMed ID: 11216016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.